One-unit compared to two-unit platelet transfusions for adult oncology outpatients.

blood components patient blood management platelet concentrates platelet transfusion refractoriness (platelets) transfusion strategy

Journal

Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 10 01 2019
revised: 17 03 2019
accepted: 10 04 2019
pubmed: 6 5 2019
medline: 18 10 2019
entrez: 7 5 2019
Statut: ppublish

Résumé

Platelet dosing has been studied in adult oncology inpatients, but there is almost no published evidence to guide platelet dosing for adult outpatients. We evaluated transfusion indices after 1 unit and 2 unit apheresis platelet transfusions at our hospital to determine whether a benefit to 2-unit transfusions could be detected. A retrospective chart review was conducted of all adult oncology patients who received an outpatient platelet transfusion over a 16-month period (July 2016-November 2017). Pre- and post-transfusion platelet count, and chronology of subsequent platelet transfusions were compared. A total of 8467 platelet transfusions were administered to 602 patients during the study period. 59·8% of patients (n = 360) were transfused interchangeably with one or two platelets throughout the study period. The primary study population were comprised of these patients. On average, a 2-unit platelet transfusions resulted in a higher immediate post-transfusion platelet count (43 vs. 37 x 10 Among adult, oncology outpatients that were transfused interchangeably with one or two units of platelets, transfusion with two platelets did not offer a durable improvement in platelet count or impact the subsequent transfusion schedule.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Platelet dosing has been studied in adult oncology inpatients, but there is almost no published evidence to guide platelet dosing for adult outpatients. We evaluated transfusion indices after 1 unit and 2 unit apheresis platelet transfusions at our hospital to determine whether a benefit to 2-unit transfusions could be detected.
MATERIALS AND METHODS METHODS
A retrospective chart review was conducted of all adult oncology patients who received an outpatient platelet transfusion over a 16-month period (July 2016-November 2017). Pre- and post-transfusion platelet count, and chronology of subsequent platelet transfusions were compared.
RESULTS RESULTS
A total of 8467 platelet transfusions were administered to 602 patients during the study period. 59·8% of patients (n = 360) were transfused interchangeably with one or two platelets throughout the study period. The primary study population were comprised of these patients. On average, a 2-unit platelet transfusions resulted in a higher immediate post-transfusion platelet count (43 vs. 37 x 10
CONCLUSION CONCLUSIONS
Among adult, oncology outpatients that were transfused interchangeably with one or two units of platelets, transfusion with two platelets did not offer a durable improvement in platelet count or impact the subsequent transfusion schedule.

Identifiants

pubmed: 31056742
doi: 10.1111/vox.12785
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

517-522

Informations de copyright

© 2019 International Society of Blood Transfusion.

Auteurs

Eric A Gehrie (EA)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Steven M Frank (SM)

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
The Armstrong Institute for Patient Safety and Quality, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Mereze Visagie (M)

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Mary K Grabowski (MK)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Aaron A R Tobian (AAR)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Valerie L Strockbine (VL)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Vincent M DeMario (VM)

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Courtney E Lawrence (CE)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Bryan C Hambley (BC)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Kristin Uglik (K)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Paul M Ness (PM)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Amy E DeZern (AE)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Evan M Bloch (EM)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH